Results 211 to 220 of about 37,728 (234)
Some of the next articles are maybe not open access.

Efficacy of probiotic‐derived lotion from Lactobacillus paracasei MSMC 39‐1 in mild to moderate acne vulgaris, randomized controlled trial

Journal of Cosmetic Dermatology, 2022
Probiotics provide benefits for reducing acne. Previous studies showed an anti‐inflammatory effect of Lactobacillus paracasei. However, the clinical evidence of topical probiotic lotion and acne treatment is still lacking.
Sunattha Sathikulpakdee   +5 more
semanticscholar   +1 more source

Anti-caries evaluation of a nano-hydroxyapatite dental lotion for use after toothbrushing: An in situ study.

E -journal of dentistry, 2021
OBJECTIVES The aim of this randomized, double-blind, two-arm crossover in situ study was to investigate whether nano-hydroxyapatite (nanoHAP) dental lotion (Apagard Deep Care) applied immediately after tooth-brushing with nanoHAP toothpaste (Apagard M ...
B. Amaechi   +9 more
semanticscholar   +1 more source

Mothers massaging their newborns with lotion versus no lotion enhances mothers’ and newborns’ sleep

open access: yesInfant Behavior and Development, 2016
Sleep is frequently interrupted in newborns and their mothers. Massage therapy is noted to facilitate sleep in adults and infants. Infant massage has also been more effective with oil versus no oil.
Jodi A Mindell, Miguel Diego
exaly   +2 more sources

0.075% capsaicin lotion for the treatment of painful diabetic neuropathy: A randomized, double-blind, crossover, placebo-controlled trial.

Journal of clinical neuroscience, 2019
OBJECTIVE A randomized, double-blinded, crossover, placebo controlled trial was conducted to evaluate the efficacy and safety of 0.075% capsaicin lotion for treating painful diabetic neuropathy (PDN).
K. Kulkantrakorn   +5 more
semanticscholar   +1 more source

Optimized formulation for topical application of a fixed combination halobetasol/tazarotene lotion using polymeric emulsion technology

Journal of dermatological treatment (Print), 2019
Background Successful clinical data on halobetasol propionate 0.01%/tazarotene 0.045% (HP/TAZ) lotion in moderate-to-severe plaque psoriasis are published. This article charts its formulation development. Methods Dermal deposition, clinical efficacy, and
E. Tanghetti   +6 more
semanticscholar   +1 more source

Optimized formulation for topical application of a fixed combination halobetasol/tazarotene lotion using polymeric emulsion technology

Journal of Dermatological Treatment, 2021
Emil Tanghetti   +2 more
exaly  

Halobetasol Propionate and Tazarotene Combination Lotion 0.01%/0.045% for Psoriasis

Current Dermatology Reports, 2021
Tina Bhutani, Nicholas Brownstone
exaly  

Home - About - Disclaimer - Privacy